Strata Critical Medical, Inc.
For the period ended Dec 31, 2025. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 3, 2026
SRTA$6.02-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity F-
Consolidated Statements of Stockholders' Equity
(in thousands, except share data)
| Common Stock · Additional Paid-In Capital · Accumulated Other Comprehensive Income · AccumulatedDeficit · Total Stockholders’ Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance as of January 1, 2024 | 75,131,425 | $7 | $390,083 | $3,964 | $(159,754) | $234,300 |
| Issuance of common stock upon exercise of stock options | 2,092,558 | — | 168 | — | — | 168 |
| Issuance of common stock upon settlement of restricted stock units | 2,871,614 | — | — | — | — | — |
| Stock-based compensation - restricted stock | — | — | 19,893 | — | — | 19,893 |
| Shares withheld related to net share settlement | (1,605,465) | — | (5,683) | — | — | (5,683) |
| Issuance of common stock for settlement of contingent consideration compensation (earn-out) | 1,008,998 | — | 3,022 | — | — | 3,022 |
| Repurchase and retirement of common stock | (80,102) | — | (407) | — | 163 | (244) |
| Other comprehensive loss | — | — | — | (2,211) | — | (2,211) |
| Net loss | — | — | — | — | (27,307) | (27,307) |
| Balance as of December 31, 2024 | 79,419,028 | $7 | $407,076 | $1,753 | $(186,898) | $221,938 |
| Issuance of common stock upon exercise of stock options | 2,188,268 | — | 193 | — | — | 193 |
| Issuance of common stock upon settlement of restricted stock units | 4,284,863 | — | — | — | — | — |
| Stock-based compensation - restricted stock | — | — | 18,038 | — | — | 18,038 |
| Shares withheld related to net share settlement | (2,624,585) | — | (9,105) | — | — | (9,105) |
| Issuance of common stock in acquisition | 3,434,609 | — | 8,414 | — | — | 8,414 |
| Other comprehensive loss | — | — | — | (1,753) | — | (1,753) |
| Net income | — | — | — | — | 41,347 | 41,347 |
| Balance as of December 31, 2025 | 86,702,183 | $7 | $424,616 | $— | $(145,551) | $279,072 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.